Search for: "HOSPIRA, INC."
Results 101 - 120
of 287
Sort by Relevance
|
Sort by Date
19 Nov 2015, 9:17 pm
Hospira, Inc. [read post]
13 Nov 2015, 1:40 pm
OEA, Inc., 270 F.3d 1353 (Fed. [read post]
13 Nov 2015, 11:35 am
Giventhat Hospira, Inc. was the original cross-appellant on theissues to be addressed, Hospira, Inc. [read post]
10 Sep 2015, 11:18 am
Hospira (Fed. [read post]
8 Sep 2015, 3:13 pm
(“Ivera”) sued Hospira, Inc. [read post]
2 Aug 2015, 4:01 pm
| Pro-Football Inc v Amanda Blackhorse et al. [read post]
27 Jul 2015, 9:35 am
| Pro-Football Inc v Amanda Blackhorse et al. [read post]
27 Jul 2015, 6:53 am
Hospira, Inc., 3-14-cv-01345 (CASD July 21, 2015, Order) (Huff, J.) [read post]
20 Jul 2015, 2:43 am
| Pro-Football Inc v Amanda Blackhorse et al. [read post]
13 Jul 2015, 10:00 pm
Hospira, Inc., the Federal Circuit held that a transaction with a contract manufacturer gave rise to an on sale bar that invalidated The Medicines Company’s Angiomax® patents. [read post]
13 Jul 2015, 3:51 am
| Plant variety in Case C‑242/14 | US Supreme Court on spiderman patent | Hospira v Genentech saga | Are EU policy-makers fighting the right copyright battles? [read post]
6 Jul 2015, 12:36 pm
In this episode (Hospira UK Ltd v Genentech Inc [2015] EWHC 1796 (Pat)), Hospira is seeking to invalidate all of Genentech's secondary patents relating to the cancer drug trastuzumab (Herceptin) so that it can market a generic version now that the SPC for the basic patent has expired.* Are EU policy-makers fighting the right copyright battles? [read post]
2 Jul 2015, 12:06 pm
Braintree Labs., Inc. v. [read post]
30 Jun 2015, 3:50 am
Another two were killed off as reported here (some claims survived in one patent, but these are apparently not of concern to Hospira); this is currently under appeal.The present case Hospira UK Ltd v Genentech Inc [2015] EWHC 1796 (Pat) concerns EP (UK) 1037926, which concerns a combination of trastuzumab with another favourite of pharmaceutical litigation, taxol (and other taxanes). [read post]
22 May 2015, 10:04 am
Hospira, Inc., 52 F. [read post]
21 May 2015, 1:09 pm
Catheter Connections, Inc. v. [read post]
28 Apr 2015, 9:14 am
’s (“Celltrion’s”) and Hospira, Inc. [read post]
25 Mar 2015, 4:42 am
Hospira, Inc., No. [read post]
9 Mar 2015, 9:59 pm
Celltrion Healthcare Co., Ltd. et al. 1:15-cv-10698; filed March 6, 2015 in the District Court of Massachusetts • Plaintiffs: Janssen Biotech, Inc.; New York University • Defendants: Celltrion Healthcare Co., Ltd.; Celltrion, Inc.; Hospira Inc. [read post]
16 Feb 2015, 1:44 am
| Hospira v Genetech Mark 1, the Appeal| Litigation-Proof Patents: Avoiding the Most Common Patent Mistakes and Patent Portfolios: Quality, Creation, and Cost reviewed | Italy and San Marino’s friendship on IP is over| Problems and imperfections in biotech patenting: realities on the ground and trying to fix the system. [read post]
